NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy
News
University of Aberdeen study finds diabetes almost doubles risk of COVID-19 death
Researchers reviewed findings from 158 global studies to determine how COVID-19 affects people living with diabetes
AbbVie and Cerebras Systems partner to accelerate AI research
Link up between AbbVie and Cerebras Systems boosts AI platforms, while radically reducing energy consumption
Evotenix receives patent for gene synthesis method
Vital patent for Evotenix is anticipated to enable a new generation of DNA synthesis platforms
University launches hub for pregnant women with pre-existing medical conditions
Norfolk and Norwich University Hospitals Foundation Trust opens centre to increase survival rate among pregnant women managing other conditions
WHO recommends Veklury for high-risk patients
WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions
Farxiga demonstrates success in preserved ejection fraction trial
DELIVER represents the largest ever trial to address heart failure with preserved ejection fraction
EC approval for post-steroid graft-versus-host treatment
Jakavi treats a potentially life-threatening condition which often effects transplant patients
Novartis Kymriah receives EC approval for lymphoma treatment
Approval for Kymriah follows a positive CHMP opinion and is applicable to all 27 EU member states
Isla Visual Record for Surveillance to aid post-surgery wound assessment
Platform will enable patients to monitor and share updates of their post-surgical wound healing
Byondis and Medac link up to commercialise trastuzumab duocarmazine
Byondis and Medac have entered into a license and collaboration agreement for form of targeted chemotherapy
Idorsia’s Quviviq approved for adults with chronic insomnia disorder
The EC’s decision on the insomnia treatment was supported by phase 3 trial results
Insulin glargine meets primary endpoint in Sanofi’s type 1 diabetes study
InRange is the first worldwide multicentre RCT to compare second generation basal insulins
NICE recommend exercise over painkillers for arthritis pain
NICE urges older people to stop routine painkiller use – over 10 million in the UK suffer a form of arthritis or other joint conditions
Scientists to trial world-first long-acting injection for high blood pressure
Long-acting hypertension treatment could provide patients with an injection of medication every six months
